- Home
- CWST vs BBIO Comparison
CWST vs BBIO Comparison
Compare CWST & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWST
- BBIO
- Stock Information
- Founded
- CWST 1975
- BBIO 2015
- Country
- CWST United States
- BBIO United States
- Employees
- CWST N/A
- BBIO N/A
- Industry
- CWST Environmental Services
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CWST Utilities
- BBIO Health Care
- Exchange
- CWST Nasdaq
- BBIO Nasdaq
- Market Cap
- CWST 5.8B
- BBIO 5.1B
- IPO Year
- CWST 1997
- BBIO 2019
- Fundamental
- Price
- CWST $106.50
- BBIO $27.82
- Analyst Decision
- CWST Strong Buy
- BBIO Strong Buy
- Analyst Count
- CWST 5
- BBIO 13
- Target Price
- CWST $114.00
- BBIO $47.92
- AVG Volume (30 Days)
- CWST 276.0K
- BBIO 2.5M
- Earning Date
- CWST 02-13-2025
- BBIO 11-12-2024
- Dividend Yield
- CWST N/A
- BBIO N/A
- EPS Growth
- CWST N/A
- BBIO N/A
- EPS
- CWST 0.12
- BBIO N/A
- Revenue
- CWST $1,489,364,000.00
- BBIO $217,765,000.00
- Revenue This Year
- CWST $24.87
- BBIO $2,648.47
- Revenue Next Year
- CWST $12.16
- BBIO N/A
- P/E Ratio
- CWST $899.56
- BBIO N/A
- Revenue Growth
- CWST 26.53
- BBIO 2209.77
- 52 Week Low
- CWST $80.04
- BBIO $21.62
- 52 Week High
- CWST $114.88
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- CWST 42.96
- BBIO 56.50
- Support Level
- CWST $108.45
- BBIO $27.00
- Resistance Level
- CWST $108.83
- BBIO $29.99
- Average True Range (ATR)
- CWST 2.14
- BBIO 1.26
- MACD
- CWST -0.95
- BBIO 0.03
- Stochastic Oscillator
- CWST 12.53
- BBIO 43.49
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.